Depression, Illness Perception, and Erectile Dysfunction Outcomes
Launched by HASEKI TRAINING AND RESEARCH HOSPITAL · May 21, 2025
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This prospective, observational study aims to investigate the relationship between illness perception and depressive symptoms in patients diagnosed with erectile dysfunction (ED), and how these factors influence treatment response over time. Erectile dysfunction is a multifactorial condition that significantly affects quality of life and can be shaped by psychological and cognitive factors, including patients' perceptions of their disease.
A total of 120 adult male participants (aged \>18 years) diagnosed with ED will be enrolled from multiple urology centers. Patients will complete three ...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male patients aged 18 years or older
- • Diagnosed with erectile dysfunction by a physician
- • Able and willing to provide written informed consent
- Exclusion Criteria:
- • History of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder)
- • Ongoing or prior hormonal therapy or active cancer treatment
- • Neurological conditions that could impact erectile function
About Haseki Training And Research Hospital
Haseki Training and Research Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Istanbul, Turkey, the hospital combines extensive clinical expertise with a commitment to excellence in research, providing a collaborative environment for healthcare professionals and researchers. With a focus on a wide range of medical disciplines, Haseki Hospital aims to contribute to the scientific community by facilitating rigorous clinical studies that adhere to the highest ethical standards, ultimately enhancing treatment options and outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Furkan Gunay, Medical doctor
Principal Investigator
Haseki Education and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported